Noonan syndrome laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Major lab findings in Noonan syndrome are coagulation factor deficiencies, platelet defects, and growth hormone deficiency.


==Lab Findings==
==Lab Findings==

Revision as of 01:59, 15 November 2013

Noonan syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Noonan syndrome from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

ECG Findings

Other Diagnostic Studies

Treatment

Management & Follow-up

Genetic Counseling

Case Studies

Case #1

Noonan syndrome laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Noonan syndrome laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Noonan syndrome laboratory findings

CDC on Noonan syndrome laboratory findings

Noonan syndrome laboratory findings in the news

Blogs on Noonan syndrome laboratory findings

Directions to Hospitals Treating Noonan syndrome

Risk calculators and risk factors for Noonan syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Serge Korjian

Overview

Major lab findings in Noonan syndrome are coagulation factor deficiencies, platelet defects, and growth hormone deficiency.

Lab Findings

Lab findings are usually non-specific in the context of Noonan syndrome. The most common findings are hematological abnormalities especially related to hemostasis. Abnormal bleeding time, prolonged aPTT and PT due to factor deficiencies and platelet defects are not uncommon. In addition, patients can also have several hematological abnormalities, that include monocytosis, thrombocytopenia, and myeloproliferative disorder.[1]

Growth hormone (GH) deficiency and resistance can be seen in Noonan syndrome accounting in part for the associated short stature. Patients with PTPN11 mutations can have increased blood levels of GH in contrast to low concentrations of IGF1.[2]

References

  1. Roberts AE, Allanson JE, Tartaglia M, Gelb BD (2013). "Noonan syndrome". Lancet. 381 (9863): 333–42. doi:10.1016/S0140-6736(12)61023-X. PMID 23312968.
  2. Binder G, Neuer K, Ranke MB, Wittekindt NE (2005). "PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome". J Clin Endocrinol Metab. 90 (9): 5377–81. doi:10.1210/jc.2005-0995. PMID 15985475.

Template:Phakomatoses and other congenital malformations not elsewhere classified


Template:WikiDoc Sources